Abstract

Calcineurin B homologous protein 3 (CHP3) is an EF-hand Ca2+-binding protein involved in regulation of cancerogenesis, cardiac hypertrophy and neuronal development through interactions with sodium/proton exchangers (NHEs) and signalling proteins. While the importance of Ca2+ binding and myristoylation for CHP3 function has been recognized, the underlying molecular mechanism remained elusive. In this study, we demonstrate that Ca2+ binding and myristoylation independently affect the conformation and functions of human CHP3. Ca2+ binding increased local flexibility and hydrophobicity of CHP3 indicative of an open conformation. The Ca2+-bound CHP3 exhibited a higher affinity for NHE1 and associated stronger with lipid membranes compared to the Mg2+-bound CHP3, which adopted a closed conformation. Myristoylation enhanced the local flexibility of CHP3 and decreased its affinity to NHE1 independently of the bound ion, but did not affect its binding to lipid membranes. The data exclude the proposed Ca2+-myristoyl switch for CHP3. Instead, a Ca2+-independent exposure of the myristoyl moiety is induced by binding of the target peptide to CHP3 enhancing its association to lipid membranes. We name this novel regulatory mechanism 'target-myristoyl switch'. Collectively, the interplay of Ca2+ binding, myristoylation, and target binding allows for a context-specific regulation of CHP3 functions.

Data availability

All data generated or analyzed during this study are included in the manuscript. Source files have been provided for Figures 1, 4, 6, and Figure 4-figure supplement 1. Data2Dynamics Software used for EC50 and KD determination is available at GitHub (https://github.com/Data2Dynamics/d2d).

Article and author information

Author details

  1. Florian Becker

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5889-8728
  2. Simon Fuchs

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
  3. Lukas Refisch

    Institute of Medical Biometry and Statistics, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9049-1944
  4. Friedel Drepper

    Institute of Biology II, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2043-5795
  5. Wolfgang Bildl

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
  6. Uwe Schulte

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    Uwe Schulte, is an employee and shareholder of Logopharm GmbH that produces ComplexioLyte 47 used in this study..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3557-0591
  7. Shuo Liang

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
  8. Jonas Immanuel Heinicke

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
  9. Sierra C Hansen

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
  10. Clemens Kreutz

    Institute of Medical Biometry and Statistics, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
  11. Bettina Warscheid

    Institute of Biology II, University of Freiburg, Freiburg, Germany
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5096-1975
  12. Bernd Fakler

    Institute of Physiology, University of Freiburg, Freiburg, Germany
    Competing interests
    Bernd Fakler, is shareholder of Logopharm GmbH. The company provides ComplexioLyte reagents to academic institutions on a non-profit basis..
  13. Evgeny V Mymrikov

    Institute of Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    For correspondence
    evgeny.mymrikov@biochemie.uni-freiburg.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4817-6278
  14. Carola Hunte

    Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany
    For correspondence
    carola.hunte@biochemie.uni-freiburg.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0826-3986

Funding

Deutsche Forschungsgemeinschaft (EXC-2189 - 390939984)

  • Clemens Kreutz
  • Bettina Warscheid
  • Bernd Fakler
  • Evgeny V Mymrikov
  • Carola Hunte

Deutsche Forschungsgemeinschaft (SFB 1381 - 403222702)

  • Uwe Schulte
  • Bettina Warscheid
  • Carola Hunte

Deutsche Forschungsgemeinschaft (SFB 1453 - 431984000)

  • Bernd Fakler
  • Carola Hunte

Deutsche Forschungsgemeinschaft (RTG 2202 - 278002225)

  • Carola Hunte

Bundesministerium für Bildung und Forschung (FKZ031L0080)

  • Clemens Kreutz

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2023, Becker et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 646
    views
  • 88
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Florian Becker
  2. Simon Fuchs
  3. Lukas Refisch
  4. Friedel Drepper
  5. Wolfgang Bildl
  6. Uwe Schulte
  7. Shuo Liang
  8. Jonas Immanuel Heinicke
  9. Sierra C Hansen
  10. Clemens Kreutz
  11. Bettina Warscheid
  12. Bernd Fakler
  13. Evgeny V Mymrikov
  14. Carola Hunte
(2023)
Conformational regulation and target-myristoyl switch of calcineurin B homologous protein 3
eLife 12:e83868.
https://doi.org/10.7554/eLife.83868

Share this article

https://doi.org/10.7554/eLife.83868

Further reading

    1. Biochemistry and Chemical Biology
    Shraddha KC, Kenny H Nguyen ... Thomas C Boothby
    Research Article

    The conformational ensemble and function of intrinsically disordered proteins (IDPs) are sensitive to their solution environment. The inherent malleability of disordered proteins, combined with the exposure of their residues, accounts for this sensitivity. One context in which IDPs play important roles that are concomitant with massive changes to the intracellular environment is during desiccation (extreme drying). The ability of organisms to survive desiccation has long been linked to the accumulation of high levels of cosolutes such as trehalose or sucrose as well as the enrichment of IDPs, such as late embryogenesis abundant (LEA) proteins or cytoplasmic abundant heat-soluble (CAHS) proteins. Despite knowing that IDPs play important roles and are co-enriched alongside endogenous, species-specific cosolutes during desiccation, little is known mechanistically about how IDP-cosolute interactions influence desiccation tolerance. Here, we test the notion that the protective function of desiccation-related IDPs is enhanced through conformational changes induced by endogenous cosolutes. We find that desiccation-related IDPs derived from four different organisms spanning two LEA protein families and the CAHS protein family synergize best with endogenous cosolutes during drying to promote desiccation protection. Yet the structural parameters of protective IDPs do not correlate with synergy for either CAHS or LEA proteins. We further demonstrate that for CAHS, but not LEA proteins, synergy is related to self-assembly and the formation of a gel. Our results suggest that functional synergy between IDPs and endogenous cosolutes is a convergent desiccation protection strategy seen among different IDP families and organisms, yet the mechanisms underlying this synergy differ between IDP families.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.